CVE-2022-48226 | An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
Zero-Day & Vulnerability Intelligence Hub
Echtzeit-Tracking mit EPSS Exploit-Wahrscheinlichkeiten, Angriffsvektor-Decodern und KI-Patch-Anleitungen.
📊 Historien-Charts — Criticals-Trend · Vendors · EPSS-Verteilung
| Tier | CVEs | Anteil |
|---|---|---|
| ≥90 % | 745 | 0,2 % |
| ≥50 % | 3.225 | 0,8 % |
| ≥10 % | 22.060 | 5,8 % |
| <10 % | 354.699 | 93,2 % |
CVE-2022-48226 | An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need